Scribe Therapeutics Inc. (SCTX) revenue

Revenue · fiscal 2025
$51.17M

Only 2 fiscal years of revenue are on record here for Scribe Therapeutics Inc. (SCTX); a history needs at least 3. Figures as of 18 Nov 2026, 10:32 UTC, from Yahoo Finance.

Key facts

Revenue, fiscal 2025
$51.17M
Change on fiscal 2024
+86.7%
Fiscal years on record
22024–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Not enough data

A history of revenue needs at least 3 fiscal years; 2 are on record here for Scribe Therapeutics Inc.. Nothing is estimated to fill the gap. What is on record is in the table below.

Scribe Therapeutics Inc. revenue, year by year

Scribe Therapeutics Inc. (SCTX) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$51.17M 86.7% up
2024$27.41M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on SCTX

Scribe Therapeutics Inc., figure by figure

Scribe Therapeutics Inc. (SCTX) overview: price, valuation and scorecard

Scribe Therapeutics Inc. revenue: questions and answers

How is Scribe Therapeutics Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Scribe Therapeutics Inc. it is on record here for 2 fiscal years, 2024 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Scribe Therapeutics Inc. (SCTX) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/SCTX/revenue

Underlying data: Yahoo Finance.